43) Genetic engineering is being used by the pharmaceutical industry. Which of the following is not
currently one of the uses?
A) production of human insulin
B) production of human growth hormone
C) production of tissue plasminogen activator
D) genetic modification of plants to produce vaccines
E) creation of products that will remove poisons from the human body
44) Genetically engineered plants
A) are more difficult to engineer than animals.
B) include a transgenic rice plant that can help prevent vitamin A deficiency.
C) are being rapidly developed, but traditional plant breeding programs are still the only method used to
develop new plants.
D) are able to fix nitrogen themselves.
E) are banned throughout the world.
45) Scientists developed a set of guidelines to address the safety of DNA technology. Which of the
following is one of the adopted safety measures?
A) Microorganisms used in recombinant DNA experiments are genetically crippled to ensure that they
cannot survive outside of the laboratory.
B) Genetically modified organisms are not allowed to be part of our food supply.
C) Transgenic plants are engineered so that the plant genes cannot hybridize.
D) Experiments involving HIV or other potentially dangerous viruses have been banned.
E) Recombinant plasmids cannot be replicated.
46) One successful form of gene therapy has involved delivery of an allele for the enzyme adenosine
deaminase (ADA) to bone marrow cells of a child with SCID, and delivery of these engineered cells
back to the bone marrow of the affected child. What is one major reason for the success of this
procedure as opposed to many other efforts at gene therapy?
A) The engineered bone marrow cells from this patient can be used for any other SCID patient.
B) The ADA-introduced allele causes all other ADA-negative cells to die.
C) The engineered cells, when reintroduced into the patient, find their way back to the bone marrow.
D) No vector is required to introduce the allele into ADA-negative cells.
E) The immune system fails to recognize cells with the variant gene.